Alimera Sciences Inc (ALIM)
3.575
+0.24
(+7.04%)
USD |
NASDAQ |
Apr 22, 16:00
Alimera Sciences Total Assets (Quarterly): 153.52M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 153.52M |
| September 30, 2023 | 154.19M |
| June 30, 2023 | 154.92M |
| March 31, 2023 | 48.24M |
| December 31, 2022 | 42.60M |
| September 30, 2022 | 43.43M |
| June 30, 2022 | 47.57M |
| March 31, 2022 | 49.93M |
| December 31, 2021 | 58.52M |
| September 30, 2021 | 60.06M |
| June 30, 2021 | 62.10M |
| March 31, 2021 | 45.59M |
| December 31, 2020 | 50.86M |
| September 30, 2020 | 49.08M |
| June 30, 2020 | 49.09M |
| March 31, 2020 | 49.00M |
| December 31, 2019 | 50.31M |
| September 30, 2019 | 46.73M |
| June 30, 2019 | 50.24M |
| March 31, 2019 | 52.31M |
| December 31, 2018 | 54.11M |
| September 30, 2018 | 51.20M |
| June 30, 2018 | 54.84M |
| March 31, 2018 | 56.12M |
| December 31, 2017 | 59.92M |
| Date | Value |
|---|---|
| September 30, 2017 | 64.76M |
| June 30, 2017 | 65.87M |
| March 31, 2017 | 62.59M |
| December 31, 2016 | 70.23M |
| September 30, 2016 | 74.98M |
| June 30, 2016 | 58.77M |
| March 31, 2016 | 62.00M |
| December 31, 2015 | 70.48M |
| September 30, 2015 | 79.01M |
| June 30, 2015 | 87.33M |
| March 31, 2015 | 96.84M |
| December 31, 2014 | 108.66M |
| September 30, 2014 | 93.29M |
| June 30, 2014 | 48.66M |
| March 31, 2014 | 47.42M |
| December 31, 2013 | 19.62M |
| September 30, 2013 | 30.54M |
| June 30, 2013 | 37.86M |
| March 31, 2013 | 43.19M |
| December 31, 2012 | 52.52M |
| September 30, 2012 | 19.83M |
| June 30, 2012 | 23.74M |
| March 31, 2012 | 28.71M |
| December 31, 2011 | 34.70M |
| September 30, 2011 | 40.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
42.60M
Minimum
Dec 2022
154.92M
Maximum
Jun 2023
66.63M
Average
49.93M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 107.35M |
| Shareholders Equity (Quarterly) | 46.17M |
| Debt to Equity Ratio | 1.397 |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -1.83% |